Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data

This is a preview and has not been published.

Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data

Authors

  • Cataldo Patruno Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy
  • Claudio Pelucchi Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
  • Carlotta Galeone Department of Statistics, Bicocca Applied Statistics Center (B-ASC), Università degli Studi di Milano-Bicocca, Milan, Italy
  • Martino Emmi Sanofi S.r.l., Milan, Italy
  • Paolo Amerio Dermatologic Clinic, Department of Medicine and Aging Science, University "G. d'Annunzio", Chieti-Pescara, Italy

Keywords:

Burden of Disease, Epidemiology, prurigo nodularis, Review

Abstract

Introduction: Prurigo nodularis (PN) is a chronic inflammatory skin disease with recent definition and relatively low prevalence. Information on PN, including its epidemiology, severity, and burden of disease is still scanty.

Objectives: We sought to review and summarize recent quantitative data on PN in Europe, and to estimate the burden of disease in Italy with a focus on moderate-to-severe PN.

Methods: We conducted a systematic literature review of recent studies on the epidemiology of PN in Europe, using PubMed/Medline and EMBASE. The study selection process was conducted independently by 2 reviewers. Articles focused on the severity of PN were also searched, and relevant information was extracted. Synthetic results were combined to population data to derive the best estimate of the burden of PN in Italian adults.

Results: Five articles reporting data on incidence and/or prevalence of PN in European populations were identified. The prevalence of PN ranged from 6.5 to 111.0 cases per 100,000, with a median estimate of 32.7 cases per 100,000, the incidence ranging between 2.88 and 20 per 100,000 person-years. Five (other) studies reported data on the severity of PN, measured through pruritus scores, quality-of-life indexes and/or percentage of non-response to treatment. We estimated a total of 16,280 prevalent PN cases in Italy, of whom 6,073 had moderate-to-severe to very severe disease. Among the latter, 1,798 estimated cases were not controlled by standard treatments.

Conclusions: We retrieved and summarized recent epidemiological data on PN, evidencing a high burden of disease in Italy and other European countries.

References

Zeidler C, Tsianakas A, Pereira M, Stander H, Yosipovitch G, Stander S. Chronic Prurigo of Nodular Type: A Review. Acta Derm Venereol. 2018. 98(2): 173-179. DOI: 10.2340/00015555-2774

Stander HF, Elmariah S, Zeidler C, Spellman M, Stander S. Diagnostic and treatment algorithm for chronic nodular prurigo. J Am Acad Dermatol. 2020. 82(2): 460-468. DOI: 10.1016/j.jaad.2019.07.022

Misery L. Chronic prurigo. (in eng), Br J Dermatol. 2022. DOI: 10.1111/bjd.21698

Stander S, Zeidler C, Augustin M, et al. S2k guideline: Diagnosis and treatment of chronic pruritus. J Dtsch Dermatol Ges. 2022. 20(10): 1387-1402. DOI: 10.1111/ddg.14830

Pereira MP, Basta S, Moore J, Stander S. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need. J Eur Acad Dermatol Venereol. 2018. 32(12): 2224-2229. DOI: 10.1111/jdv.15107

Pereira MP, Steinke S, Zeidler C, et al. European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018. 32(7): 1059-1065. DOI: 10.1111/jdv.14570

Gründel S, Pereira MP, Storck M, et al. Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment. (in eng), Acta Derm Venereol. 2020. 100(16): adv00269. DOI: 10.2340/00015555-3571

Pereira MP, Hoffmann V, Weisshaar E, et al. Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study. (in eng), J Eur Acad Dermatol Venereol. 2020. 34(10): 2373-2383. DOI: 10.1111/jdv.16309

Aggarwal P, Choi J, Sutaria N, et al. Clinical characteristics and disease burden in prurigo nodularis. (in eng), Clin Exp Dermatol. 2021. 46(7): 1277-1284. DOI: 10.1111/ced.14722

Zeidler C, Pereira MP, Stander S. Chronic Prurigo: Similar Clinical Profile and Burden Across Clinical Phenotypes. Front Med (Lausanne). 2021. 8(649332. DOI: 10.3389/fmed.2021.649332

Pereira MP, Zeidler C, Ständer S. Clinical characteristics of chronic nodular prurigo are independent of Fitzpatrick skin type: a European prospective cross-sectional study. (in eng), J Eur Acad Dermatol Venereol. 2022. 36(3): e225-e227. DOI: 10.1111/jdv.17756

Morgan CL, Thomas M, Ständer S, et al. Epidemiology of prurigo nodularis in England: a retrospective database analysis. (in eng), Br J Dermatol. 2022. 187(2): 188-195. DOI: 10.1111/bjd.21032

Stander S, Augustin M, Berger T, et al. Prevalence of prurigo nodularis in the United States of America: A retrospective database analysis. JAAD Int. 2021. 2(28-30. DOI: 10.1016/j.jdin.2020.10.009

Misery L, Brenaut E, Torreton E, Bonte J, Bouée S. Prevalence and management of chronic nodular prurigo (CNPG) in Brittany (France): estimation by matching two databases. (in eng), J Eur Acad Dermatol Venereol. 2021. 35(9): e602-e604. DOI: 10.1111/jdv.17333

Whang KA, Mahadevan V, Bakhshi PR, et al. Prevalence of prurigo nodularis in the United States. (in eng), J Allergy Clin Immunol Pract. 2020. 8(9): 3240-3241. DOI: 10.1016/j.jaip.2020.05.051

Morgan CL, Thomas M, Heywood BR, et al. Incident Comorbidity, Resource Use, and All-Cause Mortality Associated with Prurigo Nodularis: A United Kingdom Retrospective Database Analysis. (in English), JID Innovations. 2023. 3(6): DOI: 10.1016/j.xjidi.2023.100233

Ständer S, Ketz M, Akumo D, et al. Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real-world evidence claims data study. (in English), Journal of the European Academy of Dermatology and Venereology. 2023. DOI: 10.1111/jdv.19700

Ständer S, Pereira MP, Berger T, et al. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch. 2020. 5(4): e42.

Page MJ, Mckenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. 372(n71. DOI: 10.1136/bmj.n71

Bahloul D, Conlon S, Thomas RB, et al. RWD15 A Retrospective Database Study to Describe the Prevalence, Patient Characteristics and Healthcare Burden of Prurigo Nodularis (PN) in England. (in English), Value in Health. 2022. 25(12): S450. DOI: 10.1016/j.jval.2022.09.2240

Ibler KS, Torpet M, Lyngsie PJ, Olsen J, Münster M, Elberling J. EPH55 The Prevalence and Comorbidities of Prurigo Nodularis – A Danish Register-Based Study From 1995 to 2021. (in English), Value in Health. 2023. 26(12): S212. DOI: 10.1016/j.jval.2023.09.1097

Hoy D, Brooks P, Woolf A, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012. 65(9): 934-9. DOI: 10.1016/j.jclinepi.2011.11.014

Pereira MP, Zeidler C, Wallengren J, et al. Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction. (in eng), Acta Derm Venereol. 2021. 101(2): adv00403. DOI: 10.2340/00015555-3726

Misery L, Patras De Campaigno C, Jullien D, et al. EE640 Quantifying Out-of-Pocket Expenses in Patients with Prurigo Nodularis. (in English), Value in Health. 2022. 25(12): S182. DOI: 10.1016/j.jval.2022.09.879

Gabriel S, Kwatra SG, Puelles J. 34095 Observed and projected prevalence of prurigo nodularis in a commercially and Medicare-insured US population. Journal of the American Academy of Dermatology. 2022. 87(3): AB86.

Huang AH, Canner JK, Khanna R, Kang S, Kwatra SG. Real-World Prevalence of Prurigo Nodularis and Burden of Associated Diseases. J Invest Dermatol. 2020. 140(2): 480-483 e4. DOI: 10.1016/j.jid.2019.07.697

Boozalis E, Tang O, Patel S, et al. Ethnic differences and comorbidities of 909 prurigo nodularis patients. (in eng), J Am Acad Dermatol. 2018. 79(4): 714-719.e3. DOI: 10.1016/j.jaad.2018.04.047

Candelario NM, Major J, Dreyfus B, et al. Diversity in clinical trials in Europe and the USA: a review of a pharmaceutical company's data collection, reporting, and interpretation of race and ethnicity. Ann Oncol. 2023. 34(12): 1194-1197. DOI: 10.1016/j.annonc.2023.09.3107

Elmariah S, Kim B, Berger T, et al. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus. J Am Acad Dermatol. 2021. 84(3): 747-760. DOI: 10.1016/j.jaad.2020.07.025

Ryczek A, Reich A. Prevalence of Prurigo Nodularis in Poland. (in English), Acta Dermato-Venereologica. 2020. 100(10): 1-4. DOI: 10.2340/00015555-3518

Ständer S, Ketz M, Kossack N, et al. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. (in eng), Acta Derm Venereol. 2020. 100(18): adv00309. DOI: 10.2340/00015555-3655

Augustin M, Garbe C, Hagenström K, Petersen J, Pereira MP, Ständer S. Prevalence, incidence and presence of comorbidities in patients with prurigo and pruritus in Germany: A population-based claims data analysis. (in eng), J Eur Acad Dermatol Venereol. 2021. 35(11): 2270-2276. DOI: 10.1111/jdv.17485

Downloads

Published

2025-04-11

How to Cite

1.
Patruno C, Pelucchi C, Galeone C, Emmi M, Amerio P. Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data. Dermatol Pract Concept. 2025;15(2):4716. doi:10.5826/dpc.152a4716

How to Cite

1.
Patruno C, Pelucchi C, Galeone C, Emmi M, Amerio P. Epidemiology and Severity of Prurigo Nodularis In Europe: A Literature Review With an Application to Italian Data. Dermatol Pract Concept. 2025;15(2):4716. doi:10.5826/dpc.152a4716

Share